Me just dropped some major news in a tough year for the genetic testing company. After months of financial challenges, data ...

This has raised concerns about what will happen to the troves of genetic data it has in its possession. The company’s chief ...

Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.

The firm expects to save more than $35 million in annualized costs through the restructuring. CEO Anne Wojcicki told ...

The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.0616 GMT – Mega Lifesciences is facing pressure from a ...

The genetic testing company 23andMe hasn't been doing so hot lately, watching its share price plummet more than 70% this year ...

In a prepared statement, 23andMe CEO and co-founder Anne Wojcicki said the company was "taking these difficult but necessary ...

“We are taking these difficult but necessary actions as we restructure 23andMe and focus on the long-term success of our core ...

The restructuring arrives during a period of turmoil at California-based 23andMe, which has recently included a high-profile ...